Abstract
A simple, accurate and sensitive kinetic method has been developed for the determination of three cardiovascular drugs: Betaxolol, Clopidogrel, and Imidapril in pharmaceutical formulations. The method is based on the alkaline oxidation of the selected drugs with potassium manganate(VII) at room temperature (25°C) to produce a bluish-green colored product. The reaction is followed spectrophotometrically by measuring the rate of change of absorbance at 610 nm as a function of time. The fixed-time (ΔA) method is adopted for constructing the calibration curves, which were found to be linear over the concentration ranges of 0.40-2.0 μg ml-1 Betaxolol, 1.0-10.0 μg ml-1 Clopidogrel, and 6.0-16.0 μg ml-1 Imidapril. The implemented fixed times were 15 min for Betaxolol and Clopidogrel and 10 min for Imidapril. The proposed method has been successfully applied to pharmaceutical formulations of each drug. The percentage relative error and the coefficient of variation were less than 0.6 and 1.2 respectively. The lower limits of quantitation (LOQ) were 9.75x10-7 M Betaxolol, 3.62x10-6 M Clopidogrel, and 4.22x10-6 M Imidapril. The determination of the investigated drugs by the fixed-concentration and the rate-constant methods is feasible with the regression equations obtained, but the fixed-time method proves to be more applicable.
Keywords: Betaxolol, Clopidogrel, Imidapril, Potassium manganate(VII), Kinetic spectrophotometry
Current Analytical Chemistry
Title: Kinetic Spectrophotometric Determination of Betaxolol, Clopidogrel and Imidapril in Pharmaceutical Preparations
Volume: 6 Issue: 3
Author(s): Fawzy A. El Yazbi, Mohamad E. Mahrous, Hassan H. Hammud, Ghassan M. Sonji and Nada M. Sonji
Affiliation:
Keywords: Betaxolol, Clopidogrel, Imidapril, Potassium manganate(VII), Kinetic spectrophotometry
Abstract: A simple, accurate and sensitive kinetic method has been developed for the determination of three cardiovascular drugs: Betaxolol, Clopidogrel, and Imidapril in pharmaceutical formulations. The method is based on the alkaline oxidation of the selected drugs with potassium manganate(VII) at room temperature (25°C) to produce a bluish-green colored product. The reaction is followed spectrophotometrically by measuring the rate of change of absorbance at 610 nm as a function of time. The fixed-time (ΔA) method is adopted for constructing the calibration curves, which were found to be linear over the concentration ranges of 0.40-2.0 μg ml-1 Betaxolol, 1.0-10.0 μg ml-1 Clopidogrel, and 6.0-16.0 μg ml-1 Imidapril. The implemented fixed times were 15 min for Betaxolol and Clopidogrel and 10 min for Imidapril. The proposed method has been successfully applied to pharmaceutical formulations of each drug. The percentage relative error and the coefficient of variation were less than 0.6 and 1.2 respectively. The lower limits of quantitation (LOQ) were 9.75x10-7 M Betaxolol, 3.62x10-6 M Clopidogrel, and 4.22x10-6 M Imidapril. The determination of the investigated drugs by the fixed-concentration and the rate-constant methods is feasible with the regression equations obtained, but the fixed-time method proves to be more applicable.
Export Options
About this article
Cite this article as:
A. El Yazbi Fawzy, E. Mahrous Mohamad, H. Hammud Hassan, M. Sonji Ghassan and M. Sonji Nada, Kinetic Spectrophotometric Determination of Betaxolol, Clopidogrel and Imidapril in Pharmaceutical Preparations, Current Analytical Chemistry 2010; 6 (3) . https://dx.doi.org/10.2174/157341110791517007
DOI https://dx.doi.org/10.2174/157341110791517007 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Advances in Microfluidic and Sensing Technologies of Biofluids.
Detection of biological fluids is an important means to assess human health and diagnose diseases. Currently, research on blood is relatively mature and widely applied in the medical field. With the development and advancement of microfluidic technology and novel detection methods, attention has turned to human physiological fluids such as ...read more
Analytical methods for environmental and food analysis
In recent years, the study of the chemical composition of food and the environment depends on analytical methods in order to acquire information about the chemical composition, processing, quality control and contamination of soil, water, air, plants and foods, aspects very important for food safety and environmental quality control. There ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Visfatin/PBEF and Atherosclerosis-Related Diseases
Current Vascular Pharmacology Statin Attenuates High Glucose-Induced and Angiotensin II-Induced MAP Kinase Activity Through Inhibition of NAD(P)H Oxidase Activity in Cultured Mesangial Cells
Medicinal Chemistry Voltage-Gated Sodium Channels as Therapeutic Targets for Treatment of Painful Diabetic Neuropathy
Mini-Reviews in Medicinal Chemistry Psychosocial Factors and Diabetes Mellitus: Evidence-Based Treatment Guidelines
Current Diabetes Reviews All for Statins and Statins for All; An Update
Current Pharmaceutical Design Diabetic Retinopathy and Angiogenesis
Current Diabetes Reviews MicroRNAs: Biomarkers for Cardiovascular Disease in Patients with Diabetes Mellitus
Current Topics in Medicinal Chemistry TGF-β Pathway as a Therapeutic Target in Bone Metastases
Current Pharmaceutical Design Novel Therapeutic Agents for Hyperuricemia in Patients with Gout
Current Drug Therapy Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy
Current Drug Metabolism Mineralocorticoid Receptor-Associated Hypertension and Target Organ Damage: Clinical Relevance for Resistant Hypertension in End Stage Renal Disease
Current Hypertension Reviews Natural Medicine:The Genus Angelica
Current Medicinal Chemistry From Polypharmacology to Target Specificity: The Case of PARP Inhibitors
Current Topics in Medicinal Chemistry MRI findings and renal function in patients on lithium therapy
Current Drug Safety Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study
Current Drug Safety Aldose Reductase: A Multi-disease Target
Current Enzyme Inhibition CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
Current Drug Targets - Immune, Endocrine & Metabolic Disorders An Update on “Selenium Containing Compounds from Poison to Drug Candidates: A Review on the GPx-like Activity”
Current Chemical Biology Bioartificial Pancreas: Drug Delivery through Islet Microencapsulation to Treat Diabetes
Recent Patents on Biomedical Engineering (Discontinued) The Impact of Traditional Chinese Medicine on Mitophagy in Disease Models
Current Pharmaceutical Design